510(k) Report

510(k) · Cleared

Cleared

Lancet (IA, IB, IC, ID, IE, IK, IL, IM, IIA, IIB, III, V, VI, VII, VIII, IX); Lancing device (HH-X-T, HH-XV-T, HH-XVI-T, HH-XVII-T, HH-XVIII-T, HH-XIX, HH-XXI-T, HH-XXII-T, HH-XXIII-T, HH-XXIV-T, HH-XXV-T, HH-XXVI-T, HH-XXVIII-T, HH-XXIX-T, HH-XXX-T, HH-XIII-T, HH-XXVII-T)

K243306510(k) SpecialCleared Nov 15, 202425-day reviewClass II21 CFR 878.4850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tianjin Huahong Technology Co., Ltd. · QRL Multiple Use Blood Lancet For Single Patient Use Only

Cleared on Nov 15, 2024 as substantially equivalent to K220475 (Tianjin Huahong Technology Co., Ltd., 2022) after a 25-day review. Its family tree reaches back 4 generations to 2000. 3 later devices descend from it.

Decided
Nov 15, 2024
Review
25 days
Class
Class II
Product code
QRL
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to K002134 (2000). 9 ancestors in all, the oldest K822209 (1982). 3 later devices descend from it, 3 citing it directly.

  1. Root · 4 generations backK002134 One Touch Ultra Blood Glucose Monitoring SystemSelfcare, Inc. · 2000
  2. 3 generations backK090057 ON-Call Plus Blood Glucose Monitoring SystemAcon Laboratories Co. · 2009
  3. 2 generations backK113332 ON Call Chosen Lancing DeviceACON Laboratories, Inc. · 2012
  4. 1 generation backK220475 Lancet (I, II, III, V, VI); Lancing device (HH-X-T, HH-XIII-T…Tianjin Huahong Technology Co., Ltd. · 2022
  5. This deviceK243306 Lancet (IA, IB, IC, ID, IE, IK, IL, IM, IIA, IIB, III, V, VI, VII…Tianjin Huahong Technology Co., Ltd. · 2024
  6. Descendant · cites it directly · 0 of its ownK262135 Lancing deviceTianjin Huahong Technology Co., Ltd. · 2026
  7. Descendant · cites it directly · 0 of its ownK262211 LancetTianjin Huahong Technology Co., Ltd. · 2026
  8. Descendant · cites it directly · 0 of its ownK253706 Lancing device (HH-XV-T)Tianjin Huahong Technology Co., Ltd. · 2025

Most influential descendants

Showing 3 of 3 · See all
  • K262135Lancing deviceTianjin Huahong Technology Co., Ltd. · 2026 · cites it directly0descendants
  • K262211LancetTianjin Huahong Technology Co., Ltd. · 2026 · cites it directly0descendants
  • K253706Lancing device (HH-XV-T)Tianjin Huahong Technology Co., Ltd. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K002134One Touch Ultra Blood Glucose Monitoring SystemSelfcare, Inc.2000—
−3K090057ON-Call Plus Blood Glucose Monitoring SystemAcon Laboratories Co.2009—
−2K113332ON Call Chosen Lancing DeviceACON Laboratories, Inc.2012—
−1K220475Lancet (I, II, III, V, VI); Lancing device (HH-X-T, HH-XIII-T, HH-XV-T…Tianjin Huahong Technology Co., Ltd.2022—
0 (this device)K243306Lancet (IA, IB, IC, ID, IE, IK, IL, IM, IIA, IIB, III, V, VI, VII, VIII, IX)…Tianjin Huahong Technology Co., Ltd.2024—
+1K262135Lancing deviceTianjin Huahong Technology Co., Ltd.2026—
+1K262211LancetTianjin Huahong Technology Co., Ltd.2026—
+1K253706Lancing device (HH-XV-T)Tianjin Huahong Technology Co., Ltd.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198210
199310
201010
201210
201910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
202620
FIG. 1 — Lineage of K243306, 2000–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QRL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QRL device

  1. #1 K214022 Accu-Chek Softclix Blood Lancing Systemscore 38.9 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K220475Lancet (I, II, III, V, VI); Lancing device (HH-X-T, HH-XIII-T, HH-XV-T, HH-XVI-T…
Summary page 5
…ulatory Class: Class II Product code: QRL and QRK Review Panel General & Plastic Surgery III Predicate Devices 510(k) Number: K220475 Trade name: Lancet, Lancing device Classification: Class II Product Code: QRL, QRK Manufacturer: Tianjin Huah…
Tianjin Huahong Technology Co., Ltd.2022—
†K113332ON Call Chosen Lancing DeviceACON Laboratories, Inc.2012—

Also cleared against K220475: 3 other devices →

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K262135Lancing deviceTianjin Huahong Technology Co., Ltd.20260
K262211LancetTianjin Huahong Technology Co., Ltd.20260
K253706Lancing device (HH-XV-T)Tianjin Huahong Technology Co., Ltd.20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 4 companies; a new generation was cleared every 8.7 years on median.
  • None of the 9 ancestors has a recall.
  • Of its descendants, K262135 (Tianjin Huahong Technology Co., Ltd., 2026) has gone furthest, with 0 descendants of its own.
  • 3 other devices also cite its predicate K220475.

How does its category compare?

All QRL devices

QRL Multiple Use Blood Lancet For Single Patient Use Only: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · QRL

2in 2025

2022: 172023: 32024: 22025: 22026 (partial year): 3
2007high 17 (2022) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QRL

155in 2023

2022: 91 days median2023: 155 days median2026 (partial year): 54 days median
2007high 155 (2023) · low 91 (2022)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QRL

1in 2025

2025: 1
2007high 1 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QRL

133in 2025

2022: 12023: 32024: 72025: 133
2007high 133 (2025) · low 0 (2007)2025

MAUDE reports naming product code QRL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
2022179101
2023315503
20242—07
20252—1133
20263540—

What is it indicated for?

Lancet: The lancet is intended for capillary blood sampling. Lancing device: The Lancing Device is used with lancets to draw capillary blood from the fingertip, for testing utilizing small amounts of blood. The Lancing Device is intended to be used by a single patient and should not be shared. (HH-X-T, HH-XV-T, HH-XVI-T, HH-XVII-T, HH-XVIII-T, HH-XIX, HH-XXI-T, HH-XXII-T, HH-XXIII-T, HH-XXIV-T, HH-XXV-T, HH-XXVI-T, HH-XXVIII-T, HH-XXIX-T, HH-XXX-T…

Read the full statement (113 words)

Lancet:

The lancet is intended for capillary blood sampling.

Lancing device:

The Lancing Device is used with lancets to draw capillary blood from the fingertip, for testing utilizing small amounts of blood. The Lancing Device is intended to be used by a single patient and should not be shared. (HH-X-T, HH-XV-T, HH-XVI-T, HH-XVII-T, HH-XVIII-T, HH-XIX, HH-XXI-T, HH-XXII-T, HH-XXIII-T, HH-XXIV-T, HH-XXV-T, HH-XXVI-T, HH-XXVIII-T, HH-XXIX-T, HH-XXX-T, HH-XIII-T)

The Lancing Device is used with lancets to draw capillary blood from the fingertip, palm (at the base of the thumb) or forearm, for testing utilizing small amounts of blood. The Lancing Device is intended to be used by a single patient and should not be shared. (HH-XXVII-T)

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K243306: Lancet (IA, IB, IC, ID, IE, IK, IL, IM, IIA, IIB, III, V, VI, VII, VIII, IX); Lancing device (HH-X-T, HH-XV-T, HH-XVI-T, HH-XVII-T, HH-XVIII-T, HH-XIX, HH-XXI-T, HH-XXII-T, HH-XXIII-T, HH-XXIV-T, HH-XXV-T, HH-XXVI-T, HH-XXVIII-T, HH-XXIX-T, HH-XXX-T, HH-XIII-T, HH-XXVII-T).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K243306

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026